论文部分内容阅读
应用轮状病毒活疫苗LLR-85株第37代毒种，即LLR－85－37株，接种成人10人，3～6岁小儿21人，6月龄～2岁婴幼儿15人，口服一次，剂量为3×106.0TCIDEA50／ml。所有服苗者均反应轻微，未见发热、腹泻和呕吐等症状。轮状病毒1，2，3，4各型血清中和抗体4倍增长阳性率：3～6岁小儿组（20人）分别为55.0％，50.0％，63．6％和40．0％，对照组13人为0％；6月龄～2岁婴幼儿组（13人）分别为38．5％，69．2％，3％和53.8％，对照组15人为0％。初步观察结果表明LLR－85－37株口服轮状病毒活疫苗是安全、有效的。
Rotavirus live vaccine LLR-85 strains of the 37th generation, LLR-85-37 strain, inoculated 10 adults, 3 to 6 years old in 21 children, 6 months to 2 years old infants and young children 15 oral once , The dose of 3 × 106.0TCIDEA50 / ml. All clothing seedlings were mild reactions, no fever, diarrhea and vomiting and other symptoms. Rotavirus 1, 2, 3, 4 types of serum neutralizing antibodies 4-fold positive rate: 3 to 6 years old pediatric group (20) were 55.0%, 50.0%, 63.6% and 40.0% Control group, 13 were 0%; 6 months to 2 years old infants and young children group (13 people) were 38.5%, 69.2%, 3% and 53.8%, 15% of the control group was 0%. Preliminary observations show that LLR-85-37 strain of oral rotavirus live vaccine is safe and effective.